Kanagawa, Japan

Yuichi Ishikawa

USPTO Granted Patents = 2 


Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2002-2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yuichi Ishikawa: Innovator in Pharmaceuticals and Video Technology

Introduction

Yuichi Ishikawa is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the fields of pharmaceuticals and video technology. With a total of 2 patents, his work reflects a commitment to innovation and advancement in these areas.

Latest Patents

Ishikawa's latest patents include a pharmaceutical composition aimed at inhibiting the expression of iNOS and COX-2 without affecting NF-κB. This composition utilizes DTCM glutarimide as an effective ingredient, which helps in reducing nitric oxide and prostaglandin production. Additionally, he has developed a video signal transmission apparatus that features encoding means for compressively encoding video signals. This apparatus multiplexes unique identification data within an encoded bit stream, ensuring the integrity and verification of video signals during transmission.

Career Highlights

Throughout his career, Yuichi Ishikawa has worked with prominent organizations such as Sony Corporation and Keio University. His experience in these institutions has allowed him to refine his skills and contribute to groundbreaking projects in technology and pharmaceuticals.

Collaborations

Ishikawa has collaborated with notable colleagues, including Akihiko Matsumoto and Tatsuo Tsukida. These partnerships have fostered an environment of creativity and innovation, leading to the development of impactful inventions.

Conclusion

Yuichi Ishikawa's contributions to pharmaceuticals and video technology exemplify his dedication to innovation. His patents and collaborations highlight his role as a significant figure in the advancement of these fields.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…